Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFIX
|
ENSG00000008441.12 | nuclear factor I X |
NFIB
|
ENSG00000147862.10 | nuclear factor I B |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFIB | hg19_v2_chr9_-_14180778_14180808 | 0.94 | 1.5e-12 | Click! |
NFIX | hg19_v2_chr19_+_13135790_13135811 | -0.66 | 3.0e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_41614720 | 19.45 |
ENST00000509277.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
chr4_+_41614909 | 14.96 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr21_+_46020497 | 8.93 |
ENST00000380102.2
|
KRTAP10-7
|
keratin associated protein 10-7 |
chr4_-_186697044 | 8.03 |
ENST00000437304.2
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr12_+_79258444 | 7.53 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
chr6_-_130031358 | 6.85 |
ENST00000368149.2
|
ARHGAP18
|
Rho GTPase activating protein 18 |
chr11_+_59480899 | 6.51 |
ENST00000300150.7
|
STX3
|
syntaxin 3 |
chr1_+_162351503 | 6.48 |
ENST00000458626.2
|
C1orf226
|
chromosome 1 open reading frame 226 |
chr12_+_79258547 | 6.28 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr5_-_172198190 | 6.14 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr2_-_157189180 | 5.63 |
ENST00000539077.1
ENST00000424077.1 ENST00000426264.1 ENST00000339562.4 ENST00000421709.1 |
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
chr1_+_61547405 | 5.20 |
ENST00000371189.4
|
NFIA
|
nuclear factor I/A |
chr13_+_31480328 | 4.98 |
ENST00000380482.4
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis |
chr6_-_32191834 | 4.77 |
ENST00000375023.3
|
NOTCH4
|
notch 4 |
chr7_+_30960915 | 4.71 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr3_+_193853927 | 4.71 |
ENST00000232424.3
|
HES1
|
hes family bHLH transcription factor 1 |
chr1_+_78511586 | 4.68 |
ENST00000370759.3
|
GIPC2
|
GIPC PDZ domain containing family, member 2 |
chr17_+_68165657 | 4.64 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
chr16_-_30032610 | 4.62 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
chr6_-_30712313 | 4.59 |
ENST00000376377.2
ENST00000259874.5 |
IER3
|
immediate early response 3 |
chr20_-_45985464 | 4.54 |
ENST00000458360.2
ENST00000262975.4 |
ZMYND8
|
zinc finger, MYND-type containing 8 |
chr3_+_8543393 | 4.52 |
ENST00000157600.3
ENST00000415597.1 ENST00000535732.1 |
LMCD1
|
LIM and cysteine-rich domains 1 |
chr20_-_45985414 | 4.44 |
ENST00000461685.1
ENST00000372023.3 ENST00000540497.1 ENST00000435836.1 ENST00000471951.2 ENST00000352431.2 ENST00000396281.4 ENST00000355972.4 ENST00000360911.3 |
ZMYND8
|
zinc finger, MYND-type containing 8 |
chr20_-_45985172 | 4.43 |
ENST00000536340.1
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
chr3_-_64211112 | 4.43 |
ENST00000295902.6
|
PRICKLE2
|
prickle homolog 2 (Drosophila) |
chr7_+_1094921 | 4.37 |
ENST00000397095.1
|
GPR146
|
G protein-coupled receptor 146 |
chr20_+_33759854 | 4.31 |
ENST00000216968.4
|
PROCR
|
protein C receptor, endothelial |
chr1_+_153746683 | 4.14 |
ENST00000271857.2
|
SLC27A3
|
solute carrier family 27 (fatty acid transporter), member 3 |
chr2_-_225266711 | 4.14 |
ENST00000389874.3
|
FAM124B
|
family with sequence similarity 124B |
chr1_+_35258592 | 4.09 |
ENST00000342280.4
ENST00000450137.1 |
GJA4
|
gap junction protein, alpha 4, 37kDa |
chr7_+_79764104 | 4.04 |
ENST00000351004.3
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
chr17_+_39394250 | 4.00 |
ENST00000254072.6
|
KRTAP9-8
|
keratin associated protein 9-8 |
chr6_-_16761678 | 3.95 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
chr3_-_171177852 | 3.91 |
ENST00000284483.8
ENST00000475336.1 ENST00000357327.5 ENST00000460047.1 ENST00000488470.1 ENST00000470834.1 |
TNIK
|
TRAF2 and NCK interacting kinase |
chr10_-_33625154 | 3.91 |
ENST00000265371.4
|
NRP1
|
neuropilin 1 |
chr14_+_24867992 | 3.88 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr7_+_102553430 | 3.85 |
ENST00000339431.4
ENST00000249377.4 |
LRRC17
|
leucine rich repeat containing 17 |
chr20_+_42544782 | 3.79 |
ENST00000423191.2
ENST00000372999.1 |
TOX2
|
TOX high mobility group box family member 2 |
chr17_-_80059726 | 3.75 |
ENST00000583053.1
|
CCDC57
|
coiled-coil domain containing 57 |
chr9_-_129884902 | 3.74 |
ENST00000373417.1
|
ANGPTL2
|
angiopoietin-like 2 |
chr4_+_156588115 | 3.72 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr10_-_64576105 | 3.70 |
ENST00000242480.3
ENST00000411732.1 |
EGR2
|
early growth response 2 |
chr20_+_37434329 | 3.64 |
ENST00000299824.1
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B |
chr3_+_8543561 | 3.56 |
ENST00000397386.3
|
LMCD1
|
LIM and cysteine-rich domains 1 |
chr12_+_53443963 | 3.53 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr9_-_100459639 | 3.52 |
ENST00000375128.4
|
XPA
|
xeroderma pigmentosum, complementation group A |
chr1_+_100111580 | 3.49 |
ENST00000605497.1
|
PALMD
|
palmdelphin |
chr3_-_105588231 | 3.49 |
ENST00000545639.1
ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr1_+_100111479 | 3.47 |
ENST00000263174.4
|
PALMD
|
palmdelphin |
chr11_-_33913708 | 3.46 |
ENST00000257818.2
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr1_+_63833261 | 3.46 |
ENST00000371108.4
|
ALG6
|
ALG6, alpha-1,3-glucosyltransferase |
chr18_-_53303123 | 3.43 |
ENST00000569357.1
ENST00000565124.1 ENST00000398339.1 |
TCF4
|
transcription factor 4 |
chr19_+_45973120 | 3.41 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr1_+_61542922 | 3.41 |
ENST00000407417.3
|
NFIA
|
nuclear factor I/A |
chr14_+_75745477 | 3.40 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr11_+_74459876 | 3.35 |
ENST00000299563.4
|
RNF169
|
ring finger protein 169 |
chr9_-_129885010 | 3.31 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
chr4_+_30721968 | 3.30 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
chr20_+_42574317 | 3.25 |
ENST00000358131.5
|
TOX2
|
TOX high mobility group box family member 2 |
chr3_-_168864427 | 3.23 |
ENST00000468789.1
|
MECOM
|
MDS1 and EVI1 complex locus |
chr9_-_140196703 | 3.17 |
ENST00000356628.2
|
NRARP
|
NOTCH-regulated ankyrin repeat protein |
chr7_+_30951461 | 3.16 |
ENST00000311813.4
|
AQP1
|
aquaporin 1 (Colton blood group) |
chr1_-_209979465 | 3.11 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
chr12_-_9268707 | 3.10 |
ENST00000318602.7
|
A2M
|
alpha-2-macroglobulin |
chr4_+_126237554 | 3.08 |
ENST00000394329.3
|
FAT4
|
FAT atypical cadherin 4 |
chr5_-_111093759 | 3.07 |
ENST00000509979.1
ENST00000513100.1 ENST00000508161.1 ENST00000455559.2 |
NREP
|
neuronal regeneration related protein |
chr12_-_52585765 | 3.05 |
ENST00000313234.5
ENST00000394815.2 |
KRT80
|
keratin 80 |
chr10_-_95360983 | 3.04 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
chr14_-_100772862 | 3.04 |
ENST00000359232.3
|
SLC25A29
|
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
chr2_-_166651191 | 3.03 |
ENST00000392701.3
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr12_-_12491608 | 2.97 |
ENST00000545735.1
|
MANSC1
|
MANSC domain containing 1 |
chr14_+_77228532 | 2.93 |
ENST00000167106.4
ENST00000554237.1 |
VASH1
|
vasohibin 1 |
chr2_+_191745535 | 2.89 |
ENST00000320717.3
|
GLS
|
glutaminase |
chr11_-_2906979 | 2.87 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr2_+_191208196 | 2.85 |
ENST00000392329.2
ENST00000322522.4 ENST00000430311.1 ENST00000541441.1 |
INPP1
|
inositol polyphosphate-1-phosphatase |
chr14_-_100772767 | 2.84 |
ENST00000392908.3
ENST00000539621.1 |
SLC25A29
|
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
chr3_+_8543533 | 2.81 |
ENST00000454244.1
|
LMCD1
|
LIM and cysteine-rich domains 1 |
chr12_-_31158902 | 2.81 |
ENST00000544329.1
ENST00000418254.2 ENST00000222396.5 |
RP11-551L14.4
|
RP11-551L14.4 |
chr3_+_32147997 | 2.80 |
ENST00000282541.5
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like |
chr1_-_209979375 | 2.75 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
chr15_+_83776324 | 2.73 |
ENST00000379390.6
ENST00000379386.4 ENST00000565774.1 ENST00000565982.1 |
TM6SF1
|
transmembrane 6 superfamily member 1 |
chr9_-_79520989 | 2.71 |
ENST00000376713.3
ENST00000376718.3 ENST00000428286.1 |
PRUNE2
|
prune homolog 2 (Drosophila) |
chr3_+_134514093 | 2.68 |
ENST00000398015.3
|
EPHB1
|
EPH receptor B1 |
chr3_-_137851220 | 2.68 |
ENST00000236709.3
|
A4GNT
|
alpha-1,4-N-acetylglucosaminyltransferase |
chr11_+_125034586 | 2.66 |
ENST00000298282.9
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
chr6_+_142623063 | 2.62 |
ENST00000296932.8
ENST00000367609.3 |
GPR126
|
G protein-coupled receptor 126 |
chr2_+_33701286 | 2.61 |
ENST00000403687.3
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr12_+_51318513 | 2.61 |
ENST00000332160.4
|
METTL7A
|
methyltransferase like 7A |
chr2_+_33172012 | 2.60 |
ENST00000404816.2
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr7_+_114562172 | 2.60 |
ENST00000393486.1
ENST00000257724.3 |
MDFIC
|
MyoD family inhibitor domain containing |
chr4_+_42399856 | 2.58 |
ENST00000319234.4
|
SHISA3
|
shisa family member 3 |
chr12_-_71003568 | 2.55 |
ENST00000547715.1
ENST00000451516.2 ENST00000538708.1 ENST00000550857.1 ENST00000261266.5 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr13_-_101327028 | 2.55 |
ENST00000328767.5
ENST00000342624.5 ENST00000376234.3 ENST00000423847.1 |
TMTC4
|
transmembrane and tetratricopeptide repeat containing 4 |
chr6_+_84743436 | 2.55 |
ENST00000257776.4
|
MRAP2
|
melanocortin 2 receptor accessory protein 2 |
chr3_-_49851313 | 2.53 |
ENST00000333486.3
|
UBA7
|
ubiquitin-like modifier activating enzyme 7 |
chr3_+_58223228 | 2.50 |
ENST00000478253.1
ENST00000295962.4 |
ABHD6
|
abhydrolase domain containing 6 |
chr19_-_11450249 | 2.49 |
ENST00000222120.3
|
RAB3D
|
RAB3D, member RAS oncogene family |
chr4_+_156587979 | 2.48 |
ENST00000511507.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr15_-_52970820 | 2.48 |
ENST00000261844.7
ENST00000399202.4 ENST00000562135.1 |
FAM214A
|
family with sequence similarity 214, member A |
chr11_+_7597639 | 2.46 |
ENST00000533792.1
|
PPFIBP2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr7_+_150688083 | 2.46 |
ENST00000297494.3
|
NOS3
|
nitric oxide synthase 3 (endothelial cell) |
chr2_+_112656048 | 2.45 |
ENST00000295408.4
|
MERTK
|
c-mer proto-oncogene tyrosine kinase |
chr9_-_130616915 | 2.44 |
ENST00000344849.3
|
ENG
|
endoglin |
chr4_-_101439242 | 2.44 |
ENST00000296420.4
|
EMCN
|
endomucin |
chr6_+_30848557 | 2.43 |
ENST00000460944.2
ENST00000324771.8 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr12_+_53443680 | 2.42 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr12_-_58212487 | 2.42 |
ENST00000549994.1
|
AVIL
|
advillin |
chr16_-_67185117 | 2.42 |
ENST00000449549.3
|
B3GNT9
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 |
chr3_-_58196939 | 2.41 |
ENST00000394549.2
ENST00000461914.3 |
DNASE1L3
|
deoxyribonuclease I-like 3 |
chr17_-_66951474 | 2.41 |
ENST00000269080.2
|
ABCA8
|
ATP-binding cassette, sub-family A (ABC1), member 8 |
chr3_-_52479043 | 2.40 |
ENST00000231721.2
ENST00000475739.1 |
SEMA3G
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G |
chr9_+_71939488 | 2.39 |
ENST00000455972.1
|
FAM189A2
|
family with sequence similarity 189, member A2 |
chr11_+_123986069 | 2.39 |
ENST00000456829.2
ENST00000361352.5 ENST00000449321.1 ENST00000392748.1 ENST00000360334.4 ENST00000392744.4 |
VWA5A
|
von Willebrand factor A domain containing 5A |
chr19_+_46002868 | 2.38 |
ENST00000396735.2
|
PPM1N
|
protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) |
chr17_-_62084241 | 2.38 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
chr21_-_46012386 | 2.38 |
ENST00000400368.1
|
KRTAP10-6
|
keratin associated protein 10-6 |
chr9_-_130617029 | 2.37 |
ENST00000373203.4
|
ENG
|
endoglin |
chr14_-_54955721 | 2.37 |
ENST00000554908.1
|
GMFB
|
glia maturation factor, beta |
chr4_+_41362796 | 2.37 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr1_+_26036093 | 2.36 |
ENST00000374329.1
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
chr13_-_28194541 | 2.35 |
ENST00000316334.3
|
LNX2
|
ligand of numb-protein X 2 |
chr14_-_38725573 | 2.35 |
ENST00000342213.2
|
CLEC14A
|
C-type lectin domain family 14, member A |
chr17_-_5487277 | 2.35 |
ENST00000572272.1
ENST00000354411.3 ENST00000577119.1 |
NLRP1
|
NLR family, pyrin domain containing 1 |
chr6_-_32145861 | 2.34 |
ENST00000336984.6
|
AGPAT1
|
1-acylglycerol-3-phosphate O-acyltransferase 1 |
chr16_+_2880296 | 2.33 |
ENST00000571723.1
|
ZG16B
|
zymogen granule protein 16B |
chr2_-_157198860 | 2.33 |
ENST00000409572.1
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
chr13_+_32838801 | 2.32 |
ENST00000542859.1
|
FRY
|
furry homolog (Drosophila) |
chrX_-_54522558 | 2.31 |
ENST00000375135.3
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1 |
chr2_-_222436988 | 2.31 |
ENST00000409854.1
ENST00000281821.2 ENST00000392071.4 ENST00000443796.1 |
EPHA4
|
EPH receptor A4 |
chr4_-_83719983 | 2.30 |
ENST00000319540.4
|
SCD5
|
stearoyl-CoA desaturase 5 |
chr2_-_225266743 | 2.29 |
ENST00000409685.3
|
FAM124B
|
family with sequence similarity 124B |
chr7_+_89841000 | 2.29 |
ENST00000287908.3
|
STEAP2
|
STEAP family member 2, metalloreductase |
chrX_-_63005405 | 2.29 |
ENST00000374878.1
ENST00000437457.2 |
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
chr8_-_93029865 | 2.27 |
ENST00000422361.2
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr10_-_131762105 | 2.27 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
chr3_-_49170522 | 2.26 |
ENST00000418109.1
|
LAMB2
|
laminin, beta 2 (laminin S) |
chr22_+_38054721 | 2.26 |
ENST00000215904.6
|
PDXP
|
pyridoxal (pyridoxine, vitamin B6) phosphatase |
chrX_+_13671225 | 2.24 |
ENST00000545566.1
ENST00000544987.1 ENST00000314720.4 |
TCEANC
|
transcription elongation factor A (SII) N-terminal and central domain containing |
chr3_-_49170405 | 2.24 |
ENST00000305544.4
ENST00000494831.1 |
LAMB2
|
laminin, beta 2 (laminin S) |
chrX_+_46433193 | 2.24 |
ENST00000276055.3
|
CHST7
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 |
chr5_-_107717058 | 2.24 |
ENST00000359660.5
|
FBXL17
|
F-box and leucine-rich repeat protein 17 |
chr14_-_98444438 | 2.23 |
ENST00000512901.2
|
C14orf64
|
chromosome 14 open reading frame 64 |
chr10_+_112631547 | 2.23 |
ENST00000280154.7
ENST00000393104.2 |
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor) |
chr22_+_25465786 | 2.22 |
ENST00000401395.1
|
KIAA1671
|
KIAA1671 |
chr10_-_72141330 | 2.22 |
ENST00000395011.1
ENST00000395010.1 |
LRRC20
|
leucine rich repeat containing 20 |
chr15_+_42867857 | 2.22 |
ENST00000290607.7
|
STARD9
|
StAR-related lipid transfer (START) domain containing 9 |
chr22_-_37915247 | 2.20 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
chr5_+_52285144 | 2.18 |
ENST00000296585.5
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
chr11_-_105948129 | 2.18 |
ENST00000526793.1
|
KBTBD3
|
kelch repeat and BTB (POZ) domain containing 3 |
chr11_-_118134997 | 2.17 |
ENST00000278937.2
|
MPZL2
|
myelin protein zero-like 2 |
chr11_+_7618413 | 2.17 |
ENST00000528883.1
|
PPFIBP2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr19_-_41903161 | 2.16 |
ENST00000602129.1
ENST00000593771.1 ENST00000596905.1 ENST00000221233.4 |
EXOSC5
|
exosome component 5 |
chr17_-_5487768 | 2.14 |
ENST00000269280.4
ENST00000345221.3 ENST00000262467.5 |
NLRP1
|
NLR family, pyrin domain containing 1 |
chr10_-_105212059 | 2.12 |
ENST00000260743.5
|
CALHM2
|
calcium homeostasis modulator 2 |
chr21_+_17792672 | 2.12 |
ENST00000602620.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr1_+_212208919 | 2.12 |
ENST00000366991.4
ENST00000542077.1 |
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila) |
chr12_-_95009837 | 2.11 |
ENST00000551457.1
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
chr1_-_33168336 | 2.10 |
ENST00000373484.3
|
SYNC
|
syncoilin, intermediate filament protein |
chr4_-_140201333 | 2.10 |
ENST00000398955.1
|
MGARP
|
mitochondria-localized glutamic acid-rich protein |
chr14_-_30396948 | 2.09 |
ENST00000331968.5
|
PRKD1
|
protein kinase D1 |
chr11_-_105948040 | 2.07 |
ENST00000534815.1
|
KBTBD3
|
kelch repeat and BTB (POZ) domain containing 3 |
chr6_+_24495185 | 2.07 |
ENST00000348925.2
|
ALDH5A1
|
aldehyde dehydrogenase 5 family, member A1 |
chr15_-_65067773 | 2.07 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
chr18_+_3466248 | 2.07 |
ENST00000581029.1
ENST00000581442.1 ENST00000579007.1 |
RP11-838N2.4
|
RP11-838N2.4 |
chr4_+_87928140 | 2.06 |
ENST00000307808.6
|
AFF1
|
AF4/FMR2 family, member 1 |
chr20_-_23030296 | 2.06 |
ENST00000377103.2
|
THBD
|
thrombomodulin |
chr10_-_116286656 | 2.04 |
ENST00000428430.1
ENST00000369266.3 ENST00000392952.3 |
ABLIM1
|
actin binding LIM protein 1 |
chr17_-_79196724 | 2.04 |
ENST00000450824.2
ENST00000575907.1 |
AZI1
|
5-azacytidine induced 1 |
chr16_-_15736881 | 2.04 |
ENST00000540441.2
|
KIAA0430
|
KIAA0430 |
chr5_-_111093167 | 2.03 |
ENST00000446294.2
ENST00000419114.2 |
NREP
|
neuronal regeneration related protein |
chr18_-_52989217 | 2.03 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
chr6_+_7727030 | 2.02 |
ENST00000283147.6
|
BMP6
|
bone morphogenetic protein 6 |
chr1_+_97187318 | 2.02 |
ENST00000609116.1
ENST00000370198.1 ENST00000370197.1 ENST00000426398.2 ENST00000394184.3 |
PTBP2
|
polypyrimidine tract binding protein 2 |
chr9_+_139606983 | 2.01 |
ENST00000371692.4
|
FAM69B
|
family with sequence similarity 69, member B |
chr11_-_2170786 | 2.01 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr10_-_105212141 | 2.01 |
ENST00000369788.3
|
CALHM2
|
calcium homeostasis modulator 2 |
chr19_-_49552363 | 2.00 |
ENST00000448456.3
ENST00000355414.2 |
CGB8
|
chorionic gonadotropin, beta polypeptide 8 |
chr4_-_103682145 | 2.00 |
ENST00000226578.4
|
MANBA
|
mannosidase, beta A, lysosomal |
chrX_+_77166172 | 2.00 |
ENST00000343533.5
ENST00000350425.4 ENST00000341514.6 |
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide |
chr7_+_192969 | 2.00 |
ENST00000313766.5
|
FAM20C
|
family with sequence similarity 20, member C |
chr10_-_93392811 | 2.00 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
chr22_+_23046750 | 2.00 |
ENST00000390307.2
|
IGLV3-22
|
immunoglobulin lambda variable 3-22 (gene/pseudogene) |
chr19_-_3700388 | 1.99 |
ENST00000589578.1
ENST00000537021.1 ENST00000539785.1 ENST00000335312.3 |
PIP5K1C
|
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma |
chr14_+_64680854 | 1.98 |
ENST00000458046.2
|
SYNE2
|
spectrin repeat containing, nuclear envelope 2 |
chr17_+_67498538 | 1.98 |
ENST00000589647.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
chr4_-_103682071 | 1.96 |
ENST00000505239.1
|
MANBA
|
mannosidase, beta A, lysosomal |
chr16_-_88770019 | 1.96 |
ENST00000541206.2
|
RNF166
|
ring finger protein 166 |
chr13_-_44453826 | 1.96 |
ENST00000444614.3
|
CCDC122
|
coiled-coil domain containing 122 |
chr3_+_16216137 | 1.93 |
ENST00000339732.5
|
GALNT15
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
chr12_-_15038779 | 1.92 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
chr5_+_68788594 | 1.91 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
chr4_-_99579733 | 1.90 |
ENST00000305798.3
|
TSPAN5
|
tetraspanin 5 |
chr2_-_190445499 | 1.90 |
ENST00000261024.2
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1 |
chr7_-_21985489 | 1.90 |
ENST00000356195.5
ENST00000447180.1 ENST00000373934.4 ENST00000457951.1 |
CDCA7L
|
cell division cycle associated 7-like |
chr21_+_45993606 | 1.90 |
ENST00000400374.3
|
KRTAP10-4
|
keratin associated protein 10-4 |
chr2_+_112656176 | 1.89 |
ENST00000421804.2
ENST00000409780.1 |
MERTK
|
c-mer proto-oncogene tyrosine kinase |
chr11_-_33891362 | 1.89 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr22_+_22936998 | 1.88 |
ENST00000390303.2
|
IGLV3-32
|
immunoglobulin lambda variable 3-32 (non-functional) |
chr7_+_94023873 | 1.88 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
chr17_-_46688334 | 1.88 |
ENST00000239165.7
|
HOXB7
|
homeobox B7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
2.8 | 16.7 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
2.7 | 8.0 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
2.7 | 8.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.0 | 6.1 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
2.0 | 5.9 | GO:2000974 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
1.4 | 4.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.3 | 3.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.3 | 3.8 | GO:0001300 | chronological cell aging(GO:0001300) |
1.2 | 3.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.2 | 4.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
1.1 | 5.6 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
1.1 | 7.7 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.1 | 3.3 | GO:0097187 | dentinogenesis(GO:0097187) |
1.0 | 6.2 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
1.0 | 3.1 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
1.0 | 2.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.9 | 2.7 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
0.9 | 2.7 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.9 | 4.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.8 | 4.2 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.8 | 2.5 | GO:0014806 | negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
0.8 | 0.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 4.1 | GO:0060935 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
0.8 | 3.9 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.8 | 3.9 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.8 | 2.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.8 | 2.3 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.8 | 3.1 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.8 | 3.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 4.6 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
0.8 | 3.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.8 | 2.3 | GO:0031247 | actin rod assembly(GO:0031247) |
0.7 | 1.5 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.7 | 2.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.7 | 1.5 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.7 | 2.2 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.7 | 5.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 3.6 | GO:1903282 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.7 | 2.8 | GO:0006272 | leading strand elongation(GO:0006272) |
0.7 | 0.7 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.7 | 3.4 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.7 | 0.7 | GO:0072209 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
0.7 | 3.4 | GO:0019075 | virus maturation(GO:0019075) |
0.7 | 3.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.7 | 5.9 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.7 | 2.0 | GO:1900159 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.6 | 2.6 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.6 | 5.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 2.5 | GO:0009956 | radial pattern formation(GO:0009956) |
0.6 | 3.1 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.6 | 2.5 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.6 | 1.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 4.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 1.8 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.6 | 1.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 1.8 | GO:0070839 | divalent metal ion export(GO:0070839) |
0.6 | 1.8 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.6 | 7.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 4.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 1.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.6 | 3.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.6 | 1.7 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.6 | 1.7 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.6 | 1.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.5 | 1.6 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.5 | 2.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.6 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.5 | 3.1 | GO:1902998 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.5 | 3.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 1.5 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.5 | 1.5 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.5 | 2.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.5 | 1.5 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.5 | 3.9 | GO:0033216 | ferric iron import(GO:0033216) |
0.5 | 1.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 1.4 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.5 | 1.9 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.5 | 1.9 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 1.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.5 | 11.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 1.4 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.4 | 1.3 | GO:2000282 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.4 | 2.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 1.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 2.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.4 | 1.8 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.4 | 1.7 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.4 | 1.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.4 | 7.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 3.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 1.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.4 | 1.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 1.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.4 | 0.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.4 | 1.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.4 | 3.7 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.4 | 1.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.4 | 1.2 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.4 | 2.0 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.4 | 3.2 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.4 | 0.8 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 2.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.4 | 2.0 | GO:1902904 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.4 | 1.2 | GO:0034059 | response to anoxia(GO:0034059) |
0.4 | 2.4 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.4 | 1.2 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.4 | 2.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 2.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.4 | 0.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.4 | 1.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 1.1 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.4 | 1.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.4 | 4.6 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.4 | 0.4 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.4 | 1.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.4 | 0.8 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.4 | 1.1 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
0.4 | 3.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 1.5 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 0.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 1.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 1.8 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.4 | 9.3 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 2.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 2.8 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.4 | 3.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 1.1 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.4 | 0.7 | GO:0036292 | DNA rewinding(GO:0036292) |
0.3 | 4.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 1.0 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.3 | 1.0 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.3 | 1.0 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 1.0 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.3 | 1.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.0 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.3 | 2.0 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.3 | 1.3 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.3 | 3.9 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.3 | 1.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 1.3 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.3 | 1.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.3 | 1.0 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.3 | 1.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.3 | 1.0 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.3 | 1.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 1.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.3 | 2.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 2.9 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.3 | 7.8 | GO:0072189 | ureter development(GO:0072189) |
0.3 | 1.6 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 2.8 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.3 | 1.5 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.3 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.3 | 0.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.3 | 3.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 0.9 | GO:1905246 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.3 | 0.3 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.3 | 1.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 1.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 2.0 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.3 | 0.6 | GO:0005985 | sucrose metabolic process(GO:0005985) |
0.3 | 1.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 2.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.9 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.3 | 2.3 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 0.9 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.3 | 1.4 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 1.4 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.3 | 2.8 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.3 | 0.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 2.5 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 3.3 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.3 | 1.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 3.6 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.3 | 3.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 2.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 0.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 4.9 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 3.5 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 5.9 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.3 | 1.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 3.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 1.1 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.3 | 1.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 1.1 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.3 | 0.5 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 0.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.3 | 0.5 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 0.3 | GO:0002605 | negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
0.3 | 1.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.3 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.3 | 1.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 1.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 0.8 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.3 | 1.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.5 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 2.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 1.0 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.3 | 1.0 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 1.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 4.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 1.0 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.2 | 1.5 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.2 | 2.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 1.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 1.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 1.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 1.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) histone H4-K12 acetylation(GO:0043983) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 1.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 1.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 1.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 2.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.5 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.2 | 5.4 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 1.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 0.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.2 | 0.9 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.7 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.2 | 2.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.2 | 1.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 1.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 2.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 0.4 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.2 | 0.7 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.2 | 0.2 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 1.1 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
0.2 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.2 | 4.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 3.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 1.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.8 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.2 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.2 | 1.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.6 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.2 | 0.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 1.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.4 | GO:0072364 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.2 | 3.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 1.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 1.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.4 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.2 | 5.6 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 0.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 | 1.6 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 2.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 3.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 1.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.4 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.2 | 0.6 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.2 | 4.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.2 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 0.4 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 1.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 1.0 | GO:1901159 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.2 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 1.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.2 | GO:1990637 | response to prolactin(GO:1990637) |
0.2 | 0.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.2 | 0.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 0.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.2 | 0.6 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.2 | 0.6 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 1.5 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.2 | 0.6 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 3.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.3 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.2 | 0.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.7 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.2 | 2.8 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.2 | 0.6 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.2 | 3.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 4.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 2.0 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 1.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.9 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 4.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 0.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.2 | 0.7 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.2 | 2.3 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
0.2 | 0.2 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.2 | 0.5 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.2 | 0.9 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.2 | 0.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 1.7 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.2 | 0.5 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.2 | 0.7 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.2 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 2.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.8 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.2 | 0.5 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.2 | 3.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.3 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.5 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.2 | 0.6 | GO:2000768 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.2 | 0.9 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 0.5 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.2 | 1.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.9 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.2 | 0.3 | GO:0048627 | myoblast development(GO:0048627) |
0.2 | 0.6 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.2 | 0.5 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.2 | 2.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.4 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 1.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.9 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.4 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 2.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 1.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 1.6 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.1 | 2.2 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 0.7 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.4 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.1 | 1.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.4 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.1 | 0.4 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.1 | 1.0 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 0.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.1 | 3.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 1.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 1.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 2.8 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.4 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.1 | 0.6 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.4 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 0.4 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 1.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 2.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.5 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.5 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.1 | 0.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 1.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.8 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 1.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.3 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 1.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 1.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.3 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.1 | 1.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.5 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 0.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 0.5 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 1.8 | GO:0090190 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 1.4 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.1 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.4 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 1.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 1.2 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 0.1 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.1 | 0.8 | GO:0030421 | defecation(GO:0030421) |
0.1 | 2.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.5 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
0.1 | 1.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.8 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 2.1 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.1 | 1.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.4 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.1 | 0.4 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.5 | GO:0009080 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.5 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.1 | 0.5 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.1 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.5 | GO:0039507 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.1 | 1.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 1.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 3.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.5 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.1 | 3.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.4 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.1 | 0.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 2.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.2 | GO:0003284 | septum primum development(GO:0003284) |
0.1 | 0.8 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 1.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 2.0 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 2.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.1 | 0.2 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.5 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 1.3 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 0.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.7 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 1.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.4 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 0.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.1 | 1.1 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 1.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.4 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.4 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 0.7 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 2.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.5 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 0.4 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 1.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.3 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 1.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 1.0 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 0.3 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.3 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.3 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.1 | 0.3 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.1 | 0.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.1 | 0.4 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 1.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.4 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.9 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.2 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 0.6 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 2.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 1.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.3 | GO:0021678 | third ventricle development(GO:0021678) |
0.1 | 0.6 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.4 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 1.0 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 1.9 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 1.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.1 | 0.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 1.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 1.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.1 | 0.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.1 | 1.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 2.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.1 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.1 | 1.9 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 2.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 1.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 1.8 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.4 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.4 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.5 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.3 | GO:0021722 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 1.7 | GO:0090109 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of adherens junction organization(GO:1903391) |
0.1 | 0.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 1.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.7 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 2.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 1.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.1 | 1.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.6 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 15.2 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.4 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.9 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.1 | 0.2 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 1.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 2.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.2 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.4 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 1.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.1 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 0.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 2.0 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.8 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.5 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.5 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 0.2 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.5 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 3.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.6 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 3.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.2 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.1 | 0.3 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.1 | 0.4 | GO:0031337 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
0.1 | 1.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.2 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.1 | 0.2 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 1.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:0031081 | nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.1 | 0.4 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
0.1 | 0.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.7 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 1.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.3 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 1.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 1.3 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 1.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.4 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.7 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 | 0.2 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 1.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.1 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
0.1 | 0.9 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 1.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 1.8 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.1 | 0.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.4 | GO:0010044 | response to aluminum ion(GO:0010044) |
0.1 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 1.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 1.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.8 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 1.2 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.1 | 1.6 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 1.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.7 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 2.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.1 | 0.1 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.3 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 2.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 0.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 1.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 1.1 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.3 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.9 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.1 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.4 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 1.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 0.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.3 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 1.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.2 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.1 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.8 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.0 | 0.5 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.1 | GO:0002818 | intracellular defense response(GO:0002818) |
0.0 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.0 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.7 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 4.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.1 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.7 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.2 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.0 | 2.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.6 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.4 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.6 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.5 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.0 | 0.0 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.0 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.1 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.0 | 1.1 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.4 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.2 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.0 | 1.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.2 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.0 | 1.1 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 1.3 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.0 | 0.7 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
0.0 | 1.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 1.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 2.5 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 1.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.3 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.5 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.4 | GO:0034205 | beta-amyloid formation(GO:0034205) |
0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 2.0 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 1.2 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
0.0 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0060455 | regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.2 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.0 | 0.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.7 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.0 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.9 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.0 | 1.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
0.0 | 0.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.1 | GO:0032571 | response to vitamin K(GO:0032571) |
0.0 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.0 | 1.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 1.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.0 | 0.3 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.6 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.0 | 0.1 | GO:0003335 | corneocyte development(GO:0003335) |
0.0 | 0.6 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.0 | 0.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.0 | 0.7 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.0 | 0.3 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.0 | 0.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.1 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.6 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 1.8 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.4 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 5.0 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.2 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.3 | GO:0051647 | nucleus localization(GO:0051647) |
0.0 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.7 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 2.5 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 | 1.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.0 | 0.2 | GO:0015820 | leucine transport(GO:0015820) |
0.0 | 0.8 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 1.5 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.7 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.0 | GO:0045575 | basophil activation(GO:0045575) |
0.0 | 0.6 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 2.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.4 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.4 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.0 | 0.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.3 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 1.1 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 1.4 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.0 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 3.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.3 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 0.2 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 1.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0015709 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.0 | 0.1 | GO:0032445 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 1.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.0 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.0 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.0 | 0.9 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.0 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.4 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.3 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.1 | GO:0098534 | centriole assembly(GO:0098534) |
0.0 | 0.0 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.0 | 0.0 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 1.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 13.7 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
2.7 | 8.2 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
1.9 | 7.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
1.6 | 4.8 | GO:0072563 | endothelial microparticle(GO:0072563) |
1.5 | 4.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.0 | 3.1 | GO:0055028 | cortical microtubule(GO:0055028) |
0.8 | 6.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.7 | 3.5 | GO:0032449 | CBM complex(GO:0032449) |
0.6 | 4.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.5 | 1.6 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.5 | 1.6 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.5 | 2.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 1.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 2.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 2.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 1.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.4 | 1.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.4 | 1.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 1.2 | GO:0036025 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.4 | 1.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 1.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 2.8 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 2.7 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.4 | 2.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.4 | 4.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 1.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.4 | 1.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.4 | 3.9 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 1.8 | GO:0031905 | early endosome lumen(GO:0031905) |
0.4 | 1.1 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.3 | 1.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.3 | 2.0 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.3 | 1.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 2.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 2.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 4.1 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 0.9 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.3 | 2.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 2.0 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.3 | 9.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 4.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 2.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 20.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 7.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 1.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 1.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 0.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 3.3 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 5.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.2 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.2 | 0.2 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.2 | 2.1 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.7 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 3.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.8 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.2 | 0.6 | GO:0005607 | laminin-1 complex(GO:0005606) laminin-2 complex(GO:0005607) |
0.2 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 2.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.8 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 7.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 2.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 1.2 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.2 | 0.6 | GO:0005715 | late recombination nodule(GO:0005715) |
0.2 | 1.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.9 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 2.2 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 4.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 0.7 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 4.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 4.1 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 2.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 2.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 0.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 0.8 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 12.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.9 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 2.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.3 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.1 | 1.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 5.9 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.8 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 6.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.5 | GO:0097196 | Shu complex(GO:0097196) |
0.1 | 0.4 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 2.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 10.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 2.6 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 1.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 1.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.7 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 1.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 2.2 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.3 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.1 | 0.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 1.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 18.0 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 1.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.7 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 2.2 | GO:0031105 | septin complex(GO:0031105) |
0.1 | 4.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 2.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.3 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.5 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 2.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.5 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.0 | GO:0031430 | M band(GO:0031430) |
0.1 | 1.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 2.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 2.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 4.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 4.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 12.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 1.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 4.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.1 | 0.2 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 2.0 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 2.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 5.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 5.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 4.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 4.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 5.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.3 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 0.2 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.1 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.1 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 1.4 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 1.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 3.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.0 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.5 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.3 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 2.6 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 3.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 20.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 1.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
0.0 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 3.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 0.3 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 1.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 2.4 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 1.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.3 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 12.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 1.1 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 3.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 2.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 1.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 1.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 1.7 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 2.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 5.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.9 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
2.3 | 13.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
2.0 | 6.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.0 | 6.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
1.0 | 3.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.0 | 7.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 2.5 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.8 | 2.4 | GO:0017129 | triglyceride binding(GO:0017129) |
0.8 | 3.8 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.7 | 3.7 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.7 | 2.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.7 | 3.6 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.7 | 2.1 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.7 | 7.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.7 | 4.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.7 | 7.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.7 | 3.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.7 | 2.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.7 | 3.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.6 | 3.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.6 | 1.8 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.6 | 1.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.6 | 1.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 3.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 7.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.6 | 1.8 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.6 | 2.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.6 | 2.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.6 | 0.6 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.6 | 16.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 3.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 1.6 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.5 | 2.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.5 | 1.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.5 | 1.5 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.5 | 5.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 8.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 1.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.5 | 1.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.5 | 2.7 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 5.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 1.4 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.4 | 1.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.4 | 1.8 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.4 | 8.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.4 | 17.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 1.7 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.4 | 1.3 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.4 | 1.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.4 | 1.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.4 | 1.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 2.1 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.4 | 1.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 1.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 1.2 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.4 | 1.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.4 | 1.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 2.0 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
0.4 | 4.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 1.6 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.4 | 1.9 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 1.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.4 | 5.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 1.5 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.4 | 1.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.4 | 1.1 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.4 | 1.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.4 | 3.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.4 | 2.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 1.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.4 | 2.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 3.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 1.4 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.4 | 2.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.4 | 1.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.3 | 2.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 1.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 1.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.3 | 3.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 2.0 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.3 | 2.0 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.3 | 3.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 1.0 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.3 | 2.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 1.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 0.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.5 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 5.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 3.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 7.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 1.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 0.8 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.3 | 1.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 3.9 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.3 | 1.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.3 | 7.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 3.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 1.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.8 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 0.5 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.3 | 2.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 0.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 1.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.3 | 1.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.3 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 1.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 0.7 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.2 | 2.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 1.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.2 | 1.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.2 | 0.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.5 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.2 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.7 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.2 | 0.9 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.2 | 4.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 0.9 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.2 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 3.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 1.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 1.1 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.2 | 0.9 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.2 | 1.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.6 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.2 | 1.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 2.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.4 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.2 | 0.6 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.2 | 0.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 0.8 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.2 | 1.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 1.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.6 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 1.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 2.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 4.3 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 5.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.6 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.2 | 1.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.7 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 4.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.9 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 0.4 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.2 | 4.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 3.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 7.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 5.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 0.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 0.5 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.2 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.8 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 2.7 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 0.5 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
0.2 | 0.7 | GO:0070404 | NADH binding(GO:0070404) |
0.2 | 0.5 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.2 | 0.8 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 1.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.2 | 1.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 2.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 5.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 0.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.2 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 2.3 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 6.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 4.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 1.7 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 4.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.9 | GO:0052848 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.1 | 1.0 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 1.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 4.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.4 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.1 | 2.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 4.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.6 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 2.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 2.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 1.0 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.1 | 0.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.4 | GO:0032093 | SAM domain binding(GO:0032093) |
0.1 | 0.4 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 2.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.5 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.1 | 0.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 2.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 1.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.5 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.1 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.8 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 2.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 2.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 5.2 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.1 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.9 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 1.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 1.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 2.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.9 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.1 | 1.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.1 | 0.7 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.6 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.4 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 1.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 2.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 1.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 1.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 3.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 1.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.6 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 2.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 3.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.8 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 3.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.1 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 4.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.3 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 0.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 1.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.2 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylcholine-translocating ATPase activity(GO:0090554) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 1.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.6 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.1 | 0.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 2.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 1.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.9 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.9 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.1 | 0.6 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.5 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 2.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.1 | 4.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.3 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 5.5 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.3 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.1 | 0.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 1.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 3.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) |
0.1 | 0.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.1 | 2.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.2 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.1 | 1.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0030395 | lactose binding(GO:0030395) |
0.1 | 0.2 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.2 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.1 | 0.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 4.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 2.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.6 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 1.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.8 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 1.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.3 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.1 | 2.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 0.2 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.1 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.1 | 2.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 2.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.4 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.3 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 0.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 1.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 0.3 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
0.1 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 1.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.6 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.4 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 5.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0000035 | acyl binding(GO:0000035) |
0.1 | 1.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 3.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 3.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 2.1 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.1 | 0.2 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 3.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 2.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.8 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.3 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 1.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 3.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 1.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 14.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.4 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 1.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.0 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 19.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 1.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 1.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.0 | 3.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 2.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.0 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.0 | 0.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 2.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 2.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 1.8 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 0.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.0 | 0.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 2.0 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 1.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 2.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.5 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 19.4 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.0 | 0.2 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.6 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.3 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 2.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 1.5 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 2.8 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.0 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.5 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.0 | 0.1 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.0 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 0.1 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 2.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.0 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.0 | 0.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 2.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.0 | 0.1 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.0 | 0.1 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.0 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.0 | 0.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 1.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
0.0 | 0.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 6.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 1.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 26.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 13.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 4.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 9.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 4.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 3.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 5.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 6.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 6.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 5.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 7.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 5.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 12.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 9.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 4.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 3.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 5.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 3.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 1.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 6.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 15.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.6 | 4.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.5 | 7.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 6.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.5 | 10.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 4.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 6.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 6.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 5.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 6.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 4.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 6.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 6.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 5.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 4.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 9.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 4.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 5.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 4.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 2.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 1.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 2.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 5.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 2.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 2.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 4.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 3.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 3.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 3.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 2.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 9.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 2.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 2.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 4.9 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 1.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 5.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 5.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 5.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 3.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 6.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 3.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 9.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 3.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 6.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.8 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 1.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 4.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 3.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 2.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.7 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 2.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 1.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 5.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 1.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 1.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 3.2 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 3.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 4.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.3 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 1.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 2.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 1.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |